These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27821465)

  • 21. Despite Distractions, Legislators Look to Address Opioid Crisis.
    Patterson J
    Mo Med; 2018; 115(6):499-500. PubMed ID: 30643329
    [No Abstract]   [Full Text] [Related]  

  • 22. What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review.
    Campbell G; Hall W; Nielsen S
    Int Rev Psychiatry; 2018 Oct; 30(5):91-106. PubMed ID: 30522342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First, do no harm: Advocating for opioid prescribing guidelines in Canadian emergency departments.
    Moore K; Lew J; Buttemer S; Kielstra L
    CJEM; 2017 Jul; 19(4):324-326. PubMed ID: 28318458
    [No Abstract]   [Full Text] [Related]  

  • 24. Opioid Addiction in Adolescents: A Background and Policy Brief.
    Wenner A; Gigli KH
    J Pediatr Health Care; 2016; 30(6):606-609. PubMed ID: 27666505
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of cannabis in response to the opioid crisis: A review of the literature.
    Vyas MB; LeBaron VT; Gilson AM
    Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Q&A with Peter Holden.
    Holden P; Stempniak M
    Hosp Health Netw; 2016 Mar; 90(3):25. PubMed ID: 27180400
    [No Abstract]   [Full Text] [Related]  

  • 27. The Opioid Epidemic and New Legislation in Massachusetts: Time For a Culture Change in Surgery?
    Kaafarani HM; Weil E; Wakeman S; Ring D
    Ann Surg; 2017 Apr; 265(4):731-733. PubMed ID: 27849666
    [No Abstract]   [Full Text] [Related]  

  • 28. The opioid crisis: the needle and the damage done.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):385. PubMed ID: 28497746
    [No Abstract]   [Full Text] [Related]  

  • 29. Opioid Overdose Hospitalizations among Medicare-Disability Beneficiaries.
    Peters JL; Durand WM; Monteiro KA; Dumenco L; George P
    J Am Board Fam Med; 2018; 31(6):881-896. PubMed ID: 30413544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Opioid Epidemic.
    Stempniak M
    Hosp Health Netw; 2016 Mar; 90(3):22-4, 26-9. PubMed ID: 27180399
    [No Abstract]   [Full Text] [Related]  

  • 31. Increasing the benefits and reducing the harms of prescription opioid analgesics.
    Hallinan R; Osborn M; Cohen M; Dobbin M; Wodak A
    Drug Alcohol Rev; 2011 May; 30(3):315-23. PubMed ID: 21545563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coupling Policymaking with Evaluation - The Case of the Opioid Crisis.
    Barnett ML; Gray J; Zink A; Jena AB
    N Engl J Med; 2017 Dec; 377(24):2306-2309. PubMed ID: 29236636
    [No Abstract]   [Full Text] [Related]  

  • 33. A Public Health Strategy for the Opioid Crisis.
    Saloner B; McGinty EE; Beletsky L; Bluthenthal R; Beyrer C; Botticelli M; Sherman SG
    Public Health Rep; 2018; 133(1_suppl):24S-34S. PubMed ID: 30426871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.
    Fischer B; Murphy Y; Rudzinski K; MacPherson D
    Int J Drug Policy; 2016 Jan; 27():23-35. PubMed ID: 26359046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using a Collective Impact Approach to Prevent Prescription Opioid Misuse, Addiction, and Overdose Deaths.
    Knighton AJ; Brunisholz KD; Reisig K; Nichols L
    Qual Manag Health Care; 2018; 27(4):237-239. PubMed ID: 30260933
    [No Abstract]   [Full Text] [Related]  

  • 36. Healthcare Reform. Opioid Crisis.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-89. PubMed ID: 30681792
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.
    Gomes T; Khuu W; Craiovan D; Martins D; Hunt J; Lee K; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
    Drug Alcohol Depend; 2018 Oct; 191():86-90. PubMed ID: 30096638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada.
    Olding M; Ivsins A; Mayer S; Betsos A; Boyd J; Sutherland C; Culbertson C; Kerr T; McNeil R
    Am J Public Health; 2020 Jun; 110(6):833-835. PubMed ID: 32298171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harm Reduction in Health Care Settings.
    Chan CA; Canver B; McNeil R; Sue KL
    Med Clin North Am; 2022 Jan; 106(1):201-217. PubMed ID: 34823731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field.
    Binswanger IA; Gordon AJ
    Subst Abus; 2016; 37(1):1-3. PubMed ID: 26820257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.